
NB Renaissance explores options for Novamont
NB Renaissance has started exploring strategic options for portfolio company Novamont, with investment banks due to pitch for advisory roles in the coming weeks, a source close to and four sources familiar with the situation said.
A sale process for the Italian bioplastics company could launch in the second half of the year, the sources said.
According to one of the sources familiar, the sponsor has decided to start considerations for Novamont after it received unsolicited approaches. A final decision about a sale is yet to be made, the source close said.
An auction could see Novamont marketed off EUR 50m-60m EBITDA, the first source familiar said, disclosing that its margin ranges between 25%-30%.
The company has been on the radar of private equity buyers in recent years, two other sources familiar said, noting that a deal now could be more logical as the company enters its sixth year of sponsor ownership.
PwC would be the frontrunner for the sale mandate, according to two of the sources and another two sources familiar with the matter. The advisor worked with NB Renaissance when Novamont acquired BioBag Group, a Norway-based supplier of low-impact solutions for waste collection and packaging, last year.
Novamont has remained resilient during the COVID-19 crisis, two of the sources familiar said. It generated EUR 287m revenues in 2020 with strong EBITDA margins, one of the sources said, noting that these figures do not include the acquisition of BioBag, which has sales in the region of EUR 41m.
On the other hand, the war in Ukraine may affect the Italian M&A pipeline, including plans to launch a sale of Novamont, one of the sources familiar said. Even with Novamont not having much exposure to the countries directly affected by the war, the situation will have an impact in the bidder universe, the same source added.
NB Renaissance acquired a 35% stake in Mater-BI, which controls Novamont at 75%, in early 2016 from the Montedison group, and Versalis owns the remaining minority stake, the second source said.
Novamont has headquarters in Novara, production plants in Terni, Bottrighe and Patrica and research laboratories in Novara, Terni and Piana di Monte Verna, according to its website.
Novamont and NB Renaissance declined to comment, Versalis did not return request for comment.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater